Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2010
TLR9-dependent induction of intestinal alpha-defensins by Toxoplasma gondiiDavid M Foureau, Daniel W Mielcarz, Laurence C Menard, et al.
Cancer Medicine|April 30, 2024
DFMO inhibition of neuroblastoma tumorigenesisDivya Gandra, David H Mulama, David M Foureau, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 5, 2025
Plasma Proteomic Profiles Among White and African American Individuals With Monoclonal Gammopathy of Unknown Significance (MGUS) and Multiple Myeloma (MM)Cindy Varga, Kip D Zimmerman, David M Foureau, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
B cells amplify IFN-gamma production by T cells via a TNF-alpha-mediated mechanismLaurence C Menard, Laurie A Minns, Sylvie Darche, et al.
Cellular and Molecular Bioengineering|February 8, 2014
<i>In vitro</i> assessment of choline dihydrogen phosphate (CDHP) as a vehicle for recombinant human interleukin-2 (rhIL-2)David M Foureau, Regina M Vrikkis, Chase P Jones, et al.
Experimental Hematology|May 14, 2024
Prognostic significance of myeloid-derived suppressor cells and systemic inflammation in newly diagnosed diffuse large B cell lymphoma treated with chemoimmunotherapyDavid M Foureau, Fei Guo, Nury M Steuerwald, et al.
Physical Chemistry Chemical Physics : PCCP|November 18, 2011
Structure and function of proteins in hydrated choline dihydrogen phosphate ionic liquidKatherine D Weaver, Regina M Vrikkis, Matthew P Van Vorst, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 28, 2022
Standardizing Clinical Workflow for Assessing Minimal Residual Disease by Flow Cytometry in Multiple MyelomaDavid M Foureau, Barry A Paul, Fei Guo, et al.
Behavioural Neurology|March 21, 2019
A Repeated Measures Pilot Comparison of Trajectories of Fluctuating Endogenous Hormones in Young Women with Traumatic Brain Injury, Healthy ControlsJanet P Niemeier, Paul B Perrin, Bradley S Hurst, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2024
The Immunogenomic Landscape of Peripheral High-Dose IL-2 Pharmacodynamics in Patients with Metastatic Renal Cell Carcinoma: A Benchmark for Next-Generation IL-2-Based ImmunotherapiesKirk D Beebe, Joel R Eisner, John Guo, et al.
Pageof 4